CRSP News — Page 2
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2018-09-21 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 1.01,8.01,9.01. |
| 2018-09-17 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 1.01,8.01,9.01. |
| 2018-09-11 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 8.01,9.01. |
| 2018-08-31 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 1.01,9.01. |
| 2018-08-07 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 2.02,9.01. |
| 2018-06-01 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 5.02,5.07,9.01. |
| 2018-05-30 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 8.01,9.01. |
| 2018-05-08 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 2.02,9.01. |
| 2018-03-08 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 2.02,9.01. |
| 2018-01-05 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 1.01,8.01,9.01. |
| 2017-12-21 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 5.02,7.01,9.01. |
| 2017-12-18 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 1.01,9.01. |
| 2017-12-07 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 8.01,9.01. |
| 2017-11-13 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 5.02,8.01,9.01. |
| 2017-11-08 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 2.02,9.01. |
| 2017-11-07 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 8.01,9.01. |
| 2017-10-02 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 5.02,9.01. |
| 2017-08-10 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 2.02,9.01. |
| 2017-08-01 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 7.01,9.01. |
| 2017-07-27 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 5.02. |
| 2017-07-25 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 5.03,9.01. |
| 2017-07-25 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 8.01,9.01. |
| 2017-06-19 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 8.01,9.01. |
| 2017-06-08 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 8.01,9.01. |
| 2017-06-02 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 5.02,5.07,9.01. |
| 2017-05-11 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 2.02,9.01. |
| 2017-05-04 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 5.02,7.01,9.01. |
| 2017-04-27 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 8.01,9.01. |
| 2017-04-13 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 8.01,9.01. |
| 2017-03-31 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 8.01,9.01. |
| 2017-03-20 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 5.02. |
| 2017-02-15 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 8.01,9.01. |
| 2016-12-16 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 1.01,7.01,8.01,9.01. |
| 2016-11-08 | Current report | SEC filing | CRISPR Therapeutics AG filed Form 8-K | CRISPR Therapeutics AG filed Form 8-K covering items 5.03,9.01. |